Home > Clinical Trials
Check All Search

Saved trials

ACTIVE_NOT_RECRUITING
NCT04482309
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
477 Enrollment(s)
89 Study location(s)
INTERVENTIONAL (PHASE2)
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer


Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
RECRUITING
NCT04379596
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
450 Enrollment(s)
100 Study location(s)
INTERVENTIONAL (PHASE2)
Gastric Cancer
NOT_YET_RECRUITING
NCT07691489
A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
27 Enrollment(s)
7 Study location(s)
INTERVENTIONAL (PHASE2)
Colorectal Cancer


Adenocarcinoma of the Colon


Adenocarcinoma of the Rectum
COMPLETED
NCT07610577
Use and Costs of P2Y12 Inhibitors After Acute Myocardial Infarction
377,753 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Acute Myocardial Infarction (AMI)
RECRUITING
NCT07015697
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
76 Enrollment(s)
31 Study location(s)
INTERVENTIONAL (PHASE1)
Recurrent or Metastatic Solid Tumors
RECRUITING
NCT06324357
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
768 Enrollment(s)
105 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Metastatic Breast Cancer


Metastatic Gastric Adenocarcinoma


Gastroesophageal Junction Adenocarcinoma


Esophageal Adenocarcinoma


Colorectal Cancer
NOT_YET_RECRUITING
NCT07619365
Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer


Advanced Breast Cancer


Metastatic Breast Cancer
COMPLETED
NCT05183178
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
17,095 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Acute Coronary Syndrome